Below you'll find a list of all posts that have been tagged as “life sciences”
Competitive intelligence has become a strategic necessity in life sciences as pipelines grow more complex and competition accelerates. This article explores how CI teams are evolving to deliver earlier, more actionable insights that support high-stakes decision-making.
Artificial intelligence is increasingly shaping life sciences competitive intelligence, but most organizations are still early in practical adoption. Sedulo Group’s research shows that while many CI teams see efficiency gains from AI, few have fully embedded it into standardized, decision-ready workflows.
The 2025 Life Sciences CI Survey Report reveals how CI functions are evolving, highlighting structural trends, the strategic value organizations place on early threat detection, and the growing yet measured role of AI in shaping competitive insight and decision-making across the industry.
A biopharma leader partnered with Sedulo on a multi-year competitive intelligence program to connect early clinical signals with commercial strategy. The engagement delivered continuous insights across 10 rare disease areas, enabling faster decisions, earlier warnings, and confident portfolio planning.
Bringing a new therapy to market is one of the riskiest bets in pharma, nearly one in three launches falls short of expectations, while 60% underperform when multiple therapies compete in the same space. Competitive intelligence (CI) isn’t just a tactical tool, when integrated early and continuously across development, it guides trial design, shapes payer strategy, and equips commercial teams to pivot ahead of competitive threats.
Pharmaceutical launches carry far-reaching risk and opportunity, demanding strategic precision from early development through to market entry. Sedulo’s guide outlines how integrating competitive intelligence, market insights, and cross-functional alignment across four stages can help transform high stakes into sustainable success.
Pharmaceutical companies need more than public data to stay ahead. Learn how integrating pharmaceutical primary intelligence fills critical gaps and uncovers real-time competitive insights.
A top pharmaceutical company partnered with Sedulo Group to leverage pharma competitive intelligence and outmaneuver competitors in a high-stakes product launch.
In pharma, the competitive landscape evolves rapidly. This post outlines how strategic competitive intelligence helps life science teams anticipate market changes, monitor rivals, and inform smarter launch, pricing, and portfolio decisions.
A U.S.-based biopharmaceutical company faced competitive pressure from upcoming cardiovascular product launches and looming generic entry. Sedulo Group delivered targeted intelligence on competitor strategies, generic threats, and market vulnerabilities through a customized monitoring program. Armed with these insights, the client implemented counter-launch tactics, adjusted pricing and distribution, and protected its market position
